跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NME-1
首页
药物
NME-1
NME-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
RADIOLABELED COMPOUNDS FOR IN VIVO IMAGING OF GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) AND TREATMENT OF GRPR-RELATED DISORDERS
EP 4499663 A1
申请人: PROVINCIAL HEALTH SERVICES AUTHORITY
优先权: 2022
CN
EP
US
WO
7 件公开
Piperazine compounds
US 8501744 B2
申请人: QUIBELL MARTIN
优先权: 2008
EP
US
6 件公开
Dihydro-dibenzo[b,e]oxepine based selective estrogren receptor modulators, compositions and methods
US 7067510 B2
申请人: LILLY CO ELI
优先权: 2005
US
4 件公开
Therapeutic Compounds
US 2008221060 A1
申请人: PRITCHARD MARTYN
优先权: 2004
EP
US
WO
3 件公开
Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
US 7625922 B2
申请人: CANCER REC TECH LTD
优先权: 2005
CN
US
3 件公开
PYRROLOBENZODIAZEPINES
US 2015126495 A1
申请人: UCL BUSINESS PLC
优先权: 2013
CN
US
3 件公开
Non-peptide GnRH antagonists
US 7365065 B2
申请人: FERRING BV
优先权: 2002
US
3 件公开
Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
US 2005176652 A1
申请人: WYETH CORP
优先权: 2003
US
2 件公开
Pentacyclic oxepines and derivatives thereof, compositions and methods
US 7271264 B2
申请人: LILLY CO ELI
优先权: 2005
US
2 件公开
Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulators
US 2006122386 A1
申请人: WALLACE OWEN B
优先权: 2005
US
2 件公开
第 1 / 3 页
上一页
下一页
药物
反馈